ALB and Hepatic steatosis: To determine whether induced expression of scFv-E06 could be used as a therapeutic approach to prevent hepatic steatosis in mice, we inoculated Speer6-ps1Tg(Alb-cre)21Mgn/J (Alb-cre) mice via tail vein with AAV8-scFv-E06 or AAV8-GFP 2 weeks before feeding mice FPC diet for 6 weeks to induce hepatic steatosis (Fig. 2A).